Resource Finder

Resources

Our Chief Research Officer Dr. Sylvia Boj discusses the advantages of HUB Organoids and how these 3D tissue cultures have enormous potential to revolutionize how we treat patients and predict therapeutic response.

Download PDF

Our Chief Research Officer Dr. Sylvia Boj discusses a recent paper that used patient-derived organoids as a test case for a new CRISPR technique and talks about the impact this technology could have in the development of organoids for regenerative medicine. Additionally, she discusses future developments in organoids, and their involvement in drug discovery and cancer research.

Download PDF